Adicet Bio Inc reports results for the quarter ended in March - Earnings Summary

ADICET Bio

10/05/2023 22:11

* Adicet Bio Inc  ACET.OQ  reported a quarterly adjusted
loss
of 72 cents​​ per share for the quarter ended in March. The mean
expectation of eight analysts for the quarter was for a loss
of 69 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Adicet Bio Inc's reported EPS for the quarter was a loss
of 72
cents​.
    * The mean earnings estimate of analysts had fallen by
about 21.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Adicet Bio Inc shares had risen by 16.8% this quarter and
lost 24.7% so far this year.
    * The company reported a quarterly loss of $30.88 million.
    * Wall Street's median 12-month price target for Adicet Bio
Inc is
$27.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 10 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
10 at 09:11 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.69          -0.72          Missed
 Dec. 31 2022      -0.28          -0.72          Missed
 Sep. 30 2022      -0.53          -0.53          Met
 Jun. 30 2022      -0.45          -0.56          Missed